Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model.

Publié en novembre 2012 American journal of respiratory cell and molecular biology

What about targeting smooth muscle remodeling in severe asthma?

American journal of respiratory cell and molecular biology

Publication précédente

Airway smooth muscle in asthma: just a target for bronchodilation?

American journal of respiratory cell and molecular biology

Publication suivante